Loading...
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We characterized tofacitinib pharmacokinetics in patients with moderate to severe UC, and the effects of covariates on variability in pharmacokinetic parameter estimates. Data were pooled from...
Na minha lista:
| Udgivet i: | Clin Pharmacol Drug Dev |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7986169/ https://ncbi.nlm.nih.gov/pubmed/33513294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.899 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|